EN DE
Watch Careteq Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Careteq Ltd (CTQ) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Careteq Ltd stock A$0.01, price A$0.01, that is 0.1% below the price, quality 44 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare AU · ISIN AU0000195240

CL Careteq Ltd logo Thin data Nov 10, 2026

Careteq Ltd

CTQ · AU
Fairly valued, weak quality

The stock costs about what our calculation considers fair.

Low debt
Fair value A$0.0100 · Fairly valued
Quality 44/100
Expensive Growth (revenue 5y +52.6 %/yr in AUD)
Revenue last quarter 18% below a year ago.
Loss-making · -6.6% net margin (TTM)
Negative free cash flow
Trails peers (2/11)
Narrow moat 12/100 · thin data
Thin data
Estimate
Watch Careteq Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

A$0.1600 A$0.0070 Fair Value A$0.0100 Jan 2022 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

58‑month range A$0.0070 – A$0.1600 · fair‑value band A$0.0097 – A$0.0102 · the A$0.0100 price screens above the A$0.0100 fair value. As of Nov 10, 2026.

Follow Careteq in your weekly email

Every Wednesday you see whether Careteq is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Careteq Limited engages in medication management and clinical governance for health, aged, and home care sectors in Australia. The company provides healthcare safety and clinical services. Careteq Limited was incorporated in 2016 and is based in Melbourne, Australia.

Stock analysis

Careteq Ltd (CTQ) currently trades at A$0.0100, while our estimate is A$0.0100, so the stock looks roughly fairly valued today (gap 0.1%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: A$0.0097 (bear) to A$0.0102 (bull), the price of A$0.0100 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Careteq Ltd reported revenue of A$6.1M in FY2026 versus A$4.4M in FY2022, a compound +8.3%/yr. Reported net income was −A$398K in FY2026.

Key figures

Market cap A$10.3M (≈ $7.1M) Micro · P/S ratio 1.69 · Dividend yield 0.9% · Net margin −6.5% · Return on equity −16.8% · Return on assets (EBIT) −16.3% (5-year average) · Operating margin −24.9% · Revenue (TTM) A$6.1M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).

What moves the price

The share trades about 47% below its 52-week high and 43% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −35% fair-value upside, at 0%, CTQ screens cheaper than that median.

Fair Value

Bear A$0.0097 Fair Value A$0.0100 Bull A$0.0102
Price A$0.0100 · Downside -0.1%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 44/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 40
How much profit the company makes from its sales and capital
Quality Growth 43
Are margins and returns getting better?
Cashflow 33
Do the profits arrive as real cash?
Financial strength 98
Debt, balance sheet and risk of trouble
Investment 76
Does it invest with discipline instead of growing at any price?
Low Volatility 29
How calm the share price moves, does not count
Price momentum 34
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 29
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−20.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+52.6%
Start year 2021 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+86.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−351.7% (2021) → −4.5% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

Watch CTQ, get fair value alerts →

Compare Careteq Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 141 stocks

Beats the industry median on 2/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 44 · Below median
Fair Value upside −0.1% · Above median
Profitability
Return on assets −10.5% · Below median
Net margin (12 months) −6.6% · Below median
Operating margin (12 months) −24.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −18.0% · Bottom 25%
Dividend yield (12 months) 0.9% · Bottom 25%
Balance sheet
Debt / equity 0.20× · Above median

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 3.18× · Pricier than median
P/S (12 months) 1.69× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)33 · sector 13
FUTURE (revenue growth)0 · sector 45
PAST (return on equity)0 · sector 0
HEALTH (low debt)90 · sector 98
DIVIDEND (yield)18 · sector 46

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Doximity, Inc DOCS $32.42 $36.16 +12% vs CTQ
Veeva Systems Inc VEEV $305.55 $337.04 +10% vs CTQ
HealthEquity, Inc HQY $103.54 $112.32 +8% vs CTQ
Waystar Holding WAY $29.30 $29.10 −1% vs CTQ
Tempus AI, Inc TEM $80.54 $52.58 −35% vs CTQ
HeartFlow, Inc HTFL $55.80 $34.82 −38% vs CTQ
Hinge Health, Inc HNGE $123.23 $51.25 −58% vs CTQ
Pro Medicus Limited PME A$207.31 A$85.12 −59% vs CTQ
BrightSpring Health Services, Inc BTSG $72.49 $25.72 −65% vs CTQ
XtalPi Holdings 2228 HK$6.37 HK$1.53 −76% vs CTQ

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Careteq Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Careteq Ltd Fair Value". https://www.fairvalue-calculator.com/stock/CTQ

Frequently asked questions

Is Careteq Ltd (CTQ) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is A$0.0100 versus a price of A$0.0100, about 0% lower (fairly valued).
What is the fair value of CTQ?
Our estimate for Careteq Ltd is A$0.0100 (as of Nov 10, 2026), built from audited fundamentals. The current price: A$0.0100.
What is the quality score of CTQ?
Careteq Ltd has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Careteq Ltd (CTQ)?
Our calculated price target is the estimate of A$0.0100 (as of Nov 10, 2026). Cautious scenario A$0.0097, optimistic scenario A$0.0102. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Careteq Ltd stock forecast for 2026?
Our estimate puts fair value at A$0.0100, about 0% lower versus a price of A$0.0100 (fairly valued). Cautious scenario A$0.0097, optimistic scenario A$0.0102. The calculation is refreshed regularly with new filings.
What is the revenue of Careteq Ltd (CTQ)?
Careteq Ltd reported trailing-twelve-month revenue of about A$6.1M (latest available figure, as of Nov 10, 2026).
Does Careteq Ltd pay a dividend?
Careteq Ltd currently shows a dividend yield of 0.88% relative to its recent price (as of Nov 10, 2026).
How much is the dividend of Careteq Ltd (CTQ)?
Careteq Ltd has a dividend yield of 0.9%.
What is the intrinsic value of Careteq Ltd (CTQ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Careteq Ltd it is A$0.0100 per share (as of Nov 10, 2026), against a price of A$0.0100.
Is Careteq Ltd stock overvalued or undervalued in 2026?
As of Nov 10, 2026, CTQ trades above its calculated fair value: price A$0.0100, fair value A$0.0100, a gap of about −0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CTQ?
No. The price is what the market pays today (A$0.0100); the fair value is what the company's own numbers justify (A$0.0100). For Careteq Ltd the two are A$0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Careteq Ltd worth?
The market values Careteq Ltd at about A$10.3M (market capitalisation, as of Nov 10, 2026). Per share that is A$0.0100; our models calculate a fair value of A$0.0100 per share.
What do the bullish and bearish scenarios say about CTQ?
Our models span a range for Careteq Ltd: cautious scenario A$0.0097, base A$0.0100, optimistic A$0.0102 per share (as of Nov 10, 2026, price A$0.0100). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Careteq Ltd (CTQ)?
Balance-sheet figures for Careteq Ltd (as of Nov 10, 2026): return on equity −16.8%, debt of 0.20 per unit of equity. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is CTQ from its 52-week high?
Careteq Ltd trades at A$0.0100, about 47% below its 52-week high of A$0.0190 and 43% above the low of A$0.0070 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0100 is for.
Which stocks are comparable to Careteq Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Tempus AI, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Careteq Ltd stock attractive at the current price?
The data as of Nov 10, 2026: price A$0.0100, calculated fair value A$0.0100 (−0%), Quality Score 44/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Careteq Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Careteq Ltd (CTQ)?
The closing price on Nov 10, 2026 was A$0.0100. Our estimate is A$0.0100, about 0% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Careteq Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band (A$0.0097 to A$0.0102), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Careteq Ltd

How large is the market capitalisation of Careteq Ltd (CTQ)?
The market capitalisation of Careteq Ltd is A$10.3M (≈ $7.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Careteq Ltd (CTQ)?
The price-to-sales ratio of Careteq Ltd is 1.69 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Careteq Ltd (CTQ)?
The dividend yield of Careteq Ltd is 0.9%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Careteq Ltd (CTQ)?
The net margin of Careteq Ltd is −6.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Careteq Ltd (CTQ)?
The return on equity (ROE) of Careteq Ltd is −16.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Careteq Ltd (CTQ)?
On an EBIT basis the return on assets of Careteq Ltd is −16.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Careteq Ltd (CTQ)?
The operating margin of Careteq Ltd is −24.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Careteq Ltd (CTQ)?
Revenue at Careteq Ltd is growing −18.0% versus a year earlier (3y avg +6.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Careteq Ltd (CTQ) generate?
The free cash flow of Careteq Ltd is −A$1.6M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Careteq Ltd (CTQ) hold?
Careteq Ltd holds more cash than debt, A$3.1M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Careteq Ltd in the live analysis

One click puts Careteq Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.